Bacteremia

• 

  Subject Areas on Research

  • "What the eyes don't see, the heart doesn't grieve over": epidemiology and risk factors for bloodstream infections following cardiac catheterization. 
  • A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection. 
  • A Systematic Review and Meta-analysis of the Prevalence of Community-Onset Bloodstream Infections among Hospitalized Patients in Africa and Asia. 
  • A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting. 
  • A pilot study comparing the neutropenic diet to a non-neutropenic diet in the allogeneic hematopoietic stem cell transplantation population. 
  • A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study. 
  • A robust platform for the synthesis of new tetracycline antibiotics. 
  • A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancer. 
  • Acute terminal ileitis associated with pneumococcal bacteremia: case report and review of pneumococcal gastrointestinal diseases. 
  • Adverse events associated with EUS and EUS with FNA. 
  • Amino acid alterations in fibronectin binding protein A (FnBPA) and bacterial genotype are associated with cardiac device related infection in Staphylococcus aureus bacteraemia. 
  • An intervention to decrease catheter-related bloodstream infections in the ICU. 
  • Assessment of similarity among coagulase-negative staphylococci from sequential blood cultures of neonates and children by pulsed-field gel electrophoresis. 
  • Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. 
  • Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. 
  • Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. 
  • Automated blood culture systems. 
  • Bacteremia Caused by Kerstersia gyiorum. 
  • Bacteremia in granulocytopenic patients in a tertiary-care general hospital. 
  • Bacteremia in lung transplant recipients in the current era. 
  • Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus. 
  • Bacteremia, central catheters, and neonates: when to pull the line. 
  • Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. 
  • Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. 
  • Bacterial endocarditis in hemodialysis patients. 
  • Bartonella species in blood of immunocompetent persons with animal and arthropod contact. 
  • Blood culture contamination with Enterococci and skin organisms: implications for surveillance definitions of primary bloodstream infections. 
  • Blood gene expression signatures predict invasive candidiasis. 
  • Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. 
  • Bloodstream Infections and Frequency of Pretreatment Associated With Age and Hospitalization Status in Sub-Saharan Africa. 
  • Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. 
  • Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality. 
  • Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. 
  • Cat germs! Pleuropulmonary pasteurella infection in an old man. 
  • Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. 
  • Catheter-related bacteremia in patients undergoing hemodialysis. 
  • Catheter-related bloodstream infections in children. 
  • Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. 
  • Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity. 
  • Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study. 
  • Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia. 
  • Choosing the right empirical antibiotics for neonates. 
  • Circulating galectin-3 in infections and non-infectious inflammatory diseases. 
  • Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. 
  • Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. 
  • Clinical identifiers of complicated Staphylococcus aureus bacteremia. 
  • Clinical importance of identifying coagulase-negative staphylococci isolated from blood cultures: evaluation of MicroScan Rapid and Dried Overnight Gram-Positive panels versus a conventional reference method. 
  • Clinical importance of increased sensitivity of BacT/Alert FAN aerobic and anaerobic blood culture bottles. 
  • Clinical management of Staphylococcus aureus bacteremia: a review. 
  • Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. 
  • Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. 
  • Clinical predictors of bloodstream infections and mortality in hospitalized Malawian children. 
  • Clinical problem-solving. Taken out of context. 
  • Clinical profile and strain relatedness of recurrent enterococcal bacteremia. 
  • Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. 
  • Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients. 
  • Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates. 
  • Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. 
  • Comparison of BACTEC MYCO/F LYTIC and WAMPOLE ISOLATOR 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country. 
  • Comparison of iodophor and alcohol pledgets with the Medi-Flex blood culture prep kit II for preventing contamination of blood cultures. 
  • Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species. 
  • Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. 
  • Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. 
  • Constructing unit-specific empiric treatment guidelines for catheter-related and primary bacteremia by determining the likelihood of inadequate therapy. 
  • Contamination of catheter-drawn blood cultures. 
  • Controlled clinical comparison of BACTEC plus anaerobic/F to standard anaerobic/F as the anaerobic companion bottle to plus aerobic/F medium for culturing blood from adults. 
  • Controlled clinical comparison of BacT/ALERT standard aerobic and standard anaerobic blood culture bottles inoculated directly or after transport in sodium polyanethol sulfonate tubes. 
  • Controlled clinical comparison of BacT/ALERT standard aerobic medium with BACTEC standard aerobic medium for culturing blood. 
  • Controlled clinical comparison of BacT/alert FA plus and FN plus blood culture media with BacT/alert FA and FN blood culture media. 
  • Controlled clinical comparison of VersaTREK and BacT/ALERT blood culture systems. 
  • Controlled clinical comparison of bioMérieux VITAL and BACTEC NR-660 blood culture systems for detection of bacteremia and fungemia in adults. 
  • Controlled clinical comparison of plastic and glass bottles of BacT/ALERT FA medium for culturing organisms from blood of adult patients. 
  • Controlled clinical comparison of plastic versus glass bottles of BacT/ALERT PF medium for culturing blood from children. 
  • Controlled clinical comparison of the BacT/ALERT FN and the standard anaerobic SN blood culture medium. 
  • Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. 
  • Controlled comparison of BACTEC 13A, MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia. 
  • Controlled comparison of BacT/Alert MB system, manual Myco/F lytic procedure, and isolator 10 system for diagnosis of Mycobacterium tuberculosis Bacteremia. 
  • Controlled comparison of bioMérieux VITAL and BACTEC NR-660 systems for detection of bacteremia and fungemia in pediatric patients. 
  • Controlled comparison of original vented aerobic fan medium with new nonvented BacT/ALERT FA medium for culturing blood. 
  • Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. 
  • Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. 
  • Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. 
  • Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. 
  • Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. 
  • Controlled multicenter evaluation of a bacteriophage-based method for rapid detection of Staphylococcus aureus in positive blood cultures. 
  • Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. 
  • Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. 
  • Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? 
  • Cytokine profiles of preterm neonates with fungal and bacterial sepsis. 
  • Daptomycin use in infants: report of two cases with peak and trough drug concentrations. 
  • Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. 
  • Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. 
  • De-escalation therapy among bacteraemic patients with community-acquired pneumonia. 
  • Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study. 
  • Detection of Bartonella species in the blood of veterinarians and veterinary technicians: a newly recognized occupational hazard? 
  • Detection of bloodstream infections in adults: how many blood cultures are needed? 
  • Detection of bloodstream pathogens in a bacille Calmette-Guérin (BCG)-vaccinated pediatric population in Malawi: a pilot study. 
  • Development of pooled suppression subtractive hybridization to analyze the pangenome of Staphylococcus aureus. 
  • Diagnosing endocarditis in patients with Staphylococcus aureus bacteremia--reply. 
  • Diagnostic microbiology updates. 
  • Dialysis access infections. 
  • Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. 
  • Dissociation rate constants of human fibronectin binding to fibronectin-binding proteins on living Staphylococcus aureus isolated from clinical patients. 
  • Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis. 
  • Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen. 
  • Early and late onset sepsis in late preterm infants. 
  • Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. 
  • Echocardiography in Staphylococcus aureus bacteremia. 
  • Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores? 
  • Editorial commentary: telephone consultation for Staphylococcus aureus bacteremia: opening Pandora's box. 
  • Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial. 
  • Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. 
  • Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. 
  • Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. 
  • Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections. 
  • Empirical antibiotic therapy for suspected early-onset bacterial sepsis. 
  • Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss. 
  • Endovascular infections caused by methicillin-resistant Staphylococcus aureus are linked to clonal complex-specific alterations in binding and invasion domains of fibronectin-binding protein A as well as the occurrence of fnbB. 
  • Enterococcus species and the central line-associated bloodstream infection surveillance definition: evaluating the importance of blood culture contamination. 
  • Enteroinvasive Escherichia coli: a cause of bacteremia in patients with AIDS. 
  • Epidemiology of bloodstream infections in a bacille Calmette-Guérin-vaccinated pediatric population in Malawi. 
  • Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping. 
  • Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. 
  • Facial cellulitis in childhood: a changing spectrum. 
  • Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. 
  • Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. 
  • Fault Tree Analysis. 
  • Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/=15 years old, Bangkok. 
  • Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. 
  • Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. 
  • Genetic variability in beta-defensins is not associated with susceptibility to Staphylococcus aureus bacteremia. 
  • Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients. 
  • Genotypic diversity of anaerobic isolates from bloodstream infections. 
  • Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection. 
  • Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? 
  • Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. 
  • Hallucinations, sensory neuropathy, and peripheral visual deficits in a young woman infected with Bartonella koehlerae. 
  • Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review. 
  • Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. 
  • Health care--associated bloodstream infections. 
  • Helicobacter canis bacteremia in a patient with fever of unknown origin. 
  • Hematogenous patellar osteomyelitis associated with human immunodeficiency virus. 
  • Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. 
  • High-frequency S-layer protein variation in Campylobacter fetus revealed by sapA mutagenesis. 
  • Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric. 
  • Hospital-Onset MRSA Bacteremia Rates Are Significantly Correlated With Sociodemographic Factors: A Step Toward Risk Adjustment. 
  • Hospitalizations for bacterial septicemia after renal transplantation in the united states. 
  • Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia. 
  • Identifying determinants of persistent MRSA bacteremia using mathematical modeling. 
  • Images in cardiovascular medicine. Left ventricular apical pseudoaneurysm: echocardiographic and intraoperative findings. 
  • Immunochemical properties of anti-DNA antibodies in the sera of patients with Escherichia coli bacteremia. 
  • Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. 
  • Importance of aggressive evaluation in patients with Staphylococcus aureus bacteremia. 
  • In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. 
  • In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. 
  • Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface. 
  • Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. 
  • Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. 
  • Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery. 
  • Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. 
  • Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections. 
  • Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy. 
  • Increased risk of Staphylococcus aureus bacteremia in hemodialysis-A nationwide study. 
  • Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. 
  • Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. 
  • Infections in patients with cystic fibrosis following lung transplantation. 
  • Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. 
  • Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. 
  • Infectious complications in extended criteria heart transplantation. 
  • Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. 
  • Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report. 
  • Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. 
  • Infective endocarditis. 
  • Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. 
  • Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. 
  • Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. 
  • Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. 
  • Intestinal Acute Graft-versus-Host Disease: A Bug Highway to the Bloodstream. 
  • Intravascular catheter-associated infections. 
  • Intravenous amoxicillin/clavulanate for the prevention of bacteraemia following dental procedures: a randomized clinical trial. 
  • Invasive Salmonella infections in areas of high and low malaria transmission intensity in Tanzania. 
  • Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania. 
  • Is an increased dwell time of a peripherally inserted catheter associated with an increased risk of bloodstream infection in infants? 
  • Is there a difference in bloodstream infections in critically ill patients associated with ready-to-use versus compounded parenteral nutrition? 
  • Late-onset bloodstream infections in hospitalized term infants. 
  • Leptotrichia sanguinegens sp. nov., a new agent of postpartum and neonatal bacteremia. 
  • Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). 
  • Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review. 
  • Management of methicillin-resistant Staphylococcus aureus bacteremia. 
  • Marijuana use and social networks in a community outbreak of meningococcal disease. 
  • Measuring the effect of inappropriate initial antibiotic therapy on outcomes of patients with Gram-negative sepsis: An imprecise science. 
  • Meningococcemia in a patient coinfected with hepatitis C virus and HIV. 
  • Metastatic complications of bloodstream infections in hemodialysis patients. 
  • Methicillin-resistant Staphylococcus aureus bacteremia after isolation from urine. 
  • Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. 
  • Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia. 
  • Molecular characterization of nontuberculous mycobacteria isolated from human cases of disseminated disease in the USA, Thailand, Malawi, and Tanzania. 
  • Moraxella catarrhalis bacteremia and preseptal cellulitis. 
  • Mortality and neurodevelopmental outcome after Staphylococcus aureus bacteremia in infants. 
  • Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. 
  • Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy. 
  • Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? 
  • No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants. 
  • Non-O1 Vibrio cholerae septicemia: case report, discussion of literature, and relevance to bioterrorism. 
  • Nonhuman primate species as models of human bacterial sepsis. 
  • Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? 
  • Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia. 
  • Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy. 
  • Outbreak of neonatal Klebsiella septicaemia at the University College Hospital, Ibadan, Nigeria. Appraisal of predisposing factors and preventive measures. 
  • Outcome of Pediatric Gastroenterology Outpatients With Fever and Central Line. 
  • Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. 
  • Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. 
  • Performance of nucleic acid amplification following extraction of 5 milliliters of whole blood for diagnosis of Mycobacterium tuberculosis bacteremia. 
  • Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study. 
  • Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies. 
  • Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. 
  • Pharmacokinetics and tolerability of single-dose daptomycin in young infants. 
  • Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. 
  • Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. 
  • Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. 
  • Plasma concentrations of tumour necrosis factor-alpha and interleukin-6 during burn wound surgery or dressing. 
  • Polymorphisms in Fibronectin Binding Proteins A and B among Staphylococcus aureus Bloodstream Isolates Are Not Associated with Arthroplasty Infection. 
  • Postconception age and other risk factors associated with mortality following Gram-negative rod bacteremia. 
  • Postoperative bacteremia secondary to surgical site infection. 
  • Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. 
  • Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus. 
  • Predicting the risk of bacteremia in childen with fever and neutropenia. 
  • Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study. 
  • Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections. 
  • Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. 
  • Predictors of nosocomial bloodstream infections in older adults. 
  • Predictors of positive cerebrospinal fluid cultures in infants with bacteremia. 
  • Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia. 
  • Prevalence of mycobacteremia among HIV-infected infants and children in northern Tanzania. 
  • Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis. 
  • Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. 
  • Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition. 
  • Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. 
  • Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide. 
  • Psychrobacter immobilis septicemia in a boy with X-linked chronic granulomatous disease and fulminant hepatic failure. 
  • Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice. 
  • Pyrogenic reactions in hemodialysis patients, Hanoi, Vietnam. 
  • Rationale for selective use of anaerobic blood cultures. 
  • Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. 
  • Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. 
  • Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. 
  • Remarks concerning testing parameters for blood cultures. 
  • Reply to DiNubile. 
  • Reply to Gilchrist et al.: Possible roles for VAC14 in multiple infectious diseases. 
  • Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria. 
  • Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST. 
  • Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. 
  • Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. 
  • Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. 
  • Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. 
  • Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. 
  • Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. 
  • Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removal. 
  • Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia. 
  • Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. 
  • Safety and efficacy of quinupristin/dalfopristin for treatment of invasive Gram-positive infections in pediatric patients. 
  • Seasonal peaks in Escherichia coli infections: possible explanations and implications. 
  • Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents. 
  • Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. 
  • Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention. 
  • Significance of Clostridium tertium bacteremia in neutropenic and nonneutropenic patients: review of 32 cases. 
  • Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. 
  • Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. 
  • Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. 
  • Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. 
  • Staphylococcus aureus bacteremia among patients with health care-associated fever. 
  • Staphylococcus aureus bacteremia and endocarditis. 
  • Staphylococcus aureus bacteremia and endocarditis. 
  • Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. 
  • Staphylococcus aureus bacteremia in patients with neutropenia. 
  • Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. 
  • Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. 
  • Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility. 
  • Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. 
  • Staphylococcus aureus bloodstream infections: definitions and treatment. 
  • Strategies to prevent central line-associated bloodstream infections in acute care hospitals. 
  • Streptococcus equi primary bacteremia in a hepatitis-C cirrhotic patient. 
  • Streptococcus pneumoniae antigen test using positive blood culture bottles as an alternative method to diagnose pneumococcal bacteremia. 
  • Struvite calculi. 
  • Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants. 
  • Sustained Reduction in Bloodstream Infections in Infants at a Large Tertiary Care Neonatal Intensive Care Unit. 
  • Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. 
  • Temporal Trends in Blood Stream Infection Isolates from Surgical Patients. 
  • The Impact of 2015 NHSN Catheter-associated Urinary Tract Infection (CAUTI) Definition Change on Central Line-associated Bloodstream Infection (CLABSI) Rates and CLABSI Prevention Efforts at an Academic Medical Center. 
  • The case against chronic venous hemodialysis access. 
  • The clinical and prognostic importance of positive blood cultures in adults. 
  • The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. 
  • The clinical utility of transesophageal echocardiography in patients with left-sided infective endocarditis. 
  • The colony-stimulating factors: use to prevent and treat neutropenia and its complications. 
  • The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. 
  • The development and evaluation of a community-based clinical diagnosis tool and treatment regimen for postpartum sepsis in Bangladesh and Pakistan. 
  • The incidence and significance of bacteremia in out of hospital cardiac arrest. 
  • The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints. 
  • The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. 
  • The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. 
  • The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia. 
  • Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. 
  • To Be a CLABSI or Not to Be a CLABSI-That is the Question: The Epidemiology of BSI in a Large ECMO Population. 
  • Towards precision medicine: Accurate predictive modeling of infectious complications in combat casualties. 
  • Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States. 
  • Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. 
  • Treatment approaches for infected hemodialysis vascular catheters. 
  • Treatment of TIPS/biliary fistula-related endotipsitis with a covered stent. 
  • Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. 
  • Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. 
  • Unrecognised Mycobacterium tuberculosis. 
  • Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. 
  • Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. 
  • Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. 
  • Utility of paired BACTEC MYCO/F LYTIC blood culture vials for detection of bacteremia, mycobacteremia, and fungemia. 
  • Validation of performance of plastic versus glass bottles for culturing anaerobes from blood in BacT/ALERT SN medium. 
  • Value of routine anaerobic blood cultures for pediatric patients. 
  • Value of terminal subcultures for blood cultures monitored by BACTEC 9240. 
  • Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet? 
  • Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedure. 
  • Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. 
  • Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. 
  • Vibrio vulnificus septicemia and leg ulcer. 
  • Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. 
  • When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. 
  • Which Comorbid Conditions Should We Be Analyzing as Risk Factors for Healthcare-Associated Infections? 
  • Whole-genome sequencing of bloodstream Staphylococcus aureus isolates does not distinguish bacteraemia from endocarditis. 
  • Why has Borrelia burgdorferi not been transmitted by blood transfusion? 
• 

  Keywords of People

  • Allen, Andrew Scott, Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
  • Clements III, Dennis Alfred, Professor Emeritus of Pediatrics, Pediatrics, Primary Care Pediatrics
  • Cohen-Wolkowiez, Michael, Professor of Pediatrics, Pediatrics, Infectious Diseases
  • Cunningham, Coleen Kathryn, Professor of Pediatrics, Pathology
  • Messina, Julia Antoinette, Assistant Professor of Medicine, Medicine, Infectious Diseases
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Moehring, Rebekah, Associate Professor of Medicine, Medicine, Infectious Diseases
  • Steinbach, William J., Samuel L. Katz Distinguished Professor of Pediatrics, Duke Innovation & Entrepreneurship
  • Tsalik, Ephraim, Associate Professor of Medicine, Molecular Genetics and Microbiology